Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
You must be a Standard 1 Year member to access this content.
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Natera, and Davis Polk & Wardwell advised the representatives of the several underwriters on the offering. Natera, Inc....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised IDEAYA Biosciences, Inc., while Davis Polk & Wardwell LLP advised Jefferies LLC in the offering. IDEAYA Biosciences, Inc. announced the SEC-registered at-the-market...
You must be a Standard 1 Year member to access this content.
Davis Polk is advising Braze on the deal. Braze (Nasdaq: BRZE) has announced that it has entered into a definitive agreement to acquire North Star, its exclusive...
You must be a Standard 1 Year member to access this content.
Jones Day advised EagleTree Capital on the deal. Lignetics Inc., the largest consumer-focused wood pellet manufacturer in the U.S., and EagleTree Capital (“EagleTree”), on behalf of...
You must be a Standard 1 Year member to access this content.
Jones Day advised Bally’s Corporation on the deal. Bally’s Corporation (NYSE: BALY), a leading U.S. omnichannel provider of land-based gaming and interactive entertainment, announced that it...
You must be a Standard 1 Year member to access this content.
